Rob Carlson – Startup Investor Profile

Rob Carlson, Managing Director at Bioeconomy Capital, focuses on investing in early-stage industrial biotechnology companies. He is an entrepreneur, author, and scientist, known for his expertise in the bioeconomy. With a background in physics, he has authored significant works on engineering life. Rob Carlson’s investments support fundamental technology advances in biological engineering and manufacturing. He serves on the boards of various biotech companies and is involved in angel investing. The investment thesis at Bioeconomy Capital revolves around the growth of biochemicals as an alternative to petrochemicals, with a focus on transitioning to biomanufacturing. Previous investments and collaborations target industrial biotechnology, emphasizing partnerships and a network of community labs. The check size for investments at Bioeconomy Capital indicates a commitment to early-stage technologies in the bioeconomy sector.

Location: Seattle, Washington

Country: United States of America

Investment Regions: EU, NA

Investment Stages: pre-seed, seed

Website: https://www.bioeconomycapital.com/

AI Reasoning: Found evidence of Rob Carlson investing in Parse Biosciences (Series A Jan 2021, Series B Feb 2022) and other activity through Bioeconomy Capital; no public investments located in 2024 or 2025. The most recent documented investment found is Feb 2022 (Parse Biosciences), which is over 12 months ago but less than 36 months – specifically ~3 years and 9 months before the present date; that places the last known investment beyond 12 months, so classified as not-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.